H.C. Wainwright Thinks VYNE Therapeutics’ Stock is Going to Recover TipRanks - 17 Mar
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $7.00. The company's shares closed last Thursday at $0... VYNE
H.C. Wainwright Thinks VYNE Therapeutics’ Stock is Going to Recover TipRanks - 17 Mar
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $7.00. The company's shares closed last Thursday at $0... VYNE